Insulet Corporation to Present at the Canaccord Genuity 34th Annual Growth Conference

Insulet Corporation to Present at the Canaccord Genuity 34th Annual Growth 
BEDFORD, MA -- (Marketwired) -- 08/01/14 --  Insulet Corporation
(NASDAQ: PODD), the leader in tubeless insulin pump technology with
its OmniPod(R) Insulin Management System, today announced the Company
will participate in the Canaccord Genuity 34th Annual Growth
Conference at the InterContinental Boston. Management is scheduled to
present an overview of the Company on Thursday, August 14, 2014 at
1:00 p.m. ET.  
During the presentation, material information concerning the Company,
its operations, strategies and prospects may be discussed. To listen
to the audio webcast of these presentations during the event, please
visit: A replay of each webcast will
be available for 10 days after the initial presentation. 
About Insulet Corporation 
 Insulet Corporation (NASDAQ: PODD) is an
innovative medical device company dedicated to making the lives of
people with diabetes easier. Through its OmniPod Insulin Management
System, Insulet seeks to expand the use of insulin pump therapy among
people with insulin-dependent diabetes. The OmniPod is a
revolutionary and easy-to-use tubeless insulin pump that features
just two parts and fully-automated cannula insertion. Insulet's
subsidiary, Neighborhood Diabetes, is a leading distributor for
diabetes products and supplies, delivered through a high touch
customer service model. To read inspiring stories of people with
diabetes living their lives to the fullest with OmniPod, visit our
customer blog, Suite D: Founded in 2000,
Insulet Corporation is based in Bedford, Mass. For more information,
please visit: 
Insulet Corporation 
877-PODD-IR1 (877-763-3471) 
Press spacebar to pause and continue. Press esc to stop.